ConductScience.org, home

Paper16633046

5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.

Hande S and 9 others. Inflamm Bowel Dis, 2006. Cited by 84 papers, by iCite.

Cite this record

ConductScience Library. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Papers, record 16633046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16633046

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
PubMed
Journal
Inflamm Bowel Dis
PubMed
Year
2006
PubMed
Publication types
Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2018-09-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hande SScott
2Wilson-Rich NNoah
3Bousvaros AAthos
4Zholudev AAnna
5Maurer RRie
6Banks PPeter
7Makrauer FFrederick
8Reddy SSarathchandra
9Burakoff RRobert
10Friedman SSonia

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory Agents, Non-SteroidalMajor topic
AzathioprineMajor topic
Immunosuppressive AgentsMajor topic
Inflammatory Bowel DiseasesMajor topic
MercaptopurineMajor topic
MesalamineMajor topic
ThioguanineMajor topic
Adolescent
Adult
Aged
Biomarkers
Child
Cross-Sectional Studies
Female
Follow-Up Studies
Humans
Male
Middle Aged
Remission Induction
Retrospective Studies
Severity of Illness Index
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
42663270Blood-test monitoring strategies for patients established on immune-suppressing drugs: a mixed-methods study.Health Technol Assess2026https://conductscience.org/library/papers/42663270PubMed
41846507The decline of 6-thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41846507PubMed
40206080Proactive pharmacogenomics in azathioprine-treated pediatric inflammatory bowel disease at a Chinese tertiary hospital.Front Pharmacol2025https://conductscience.org/library/papers/40206080PubMed
39598554Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management.Pharmaceutics2024https://conductscience.org/library/papers/39598554PubMed
38589597Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.J Gastroenterol2024https://conductscience.org/library/papers/38589597PubMed
38023976Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines.Ann Gastroenterol2023https://conductscience.org/library/papers/38023976PubMed
37959208The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review.J Clin Med2023https://conductscience.org/library/papers/37959208PubMed
37745026Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation.EClinicalMedicine2023https://conductscience.org/library/papers/37745026PubMed
34797442No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy.Dig Dis Sci2022https://conductscience.org/library/papers/34797442PubMed
34487330Advances in Thiopurine Drug Delivery: The Current State-of-the-Art.Eur J Drug Metab Pharmacokinet2021https://conductscience.org/library/papers/34487330PubMed
33929082Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients.Pharmacol Res Perspect2021https://conductscience.org/library/papers/33929082PubMed
33755823Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.Dig Dis Sci2022https://conductscience.org/library/papers/33755823PubMed
32668748Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis.J Clin Med2020https://conductscience.org/library/papers/32668748PubMed
32573825No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy.Aliment Pharmacol Ther2020https://conductscience.org/library/papers/32573825PubMed
29752633Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis.Clin Pharmacokinet2019https://conductscience.org/library/papers/29752633PubMed
28839543Optimising use of thiopurines in inflammatory bowel disease.Frontline Gastroenterol2010https://conductscience.org/library/papers/28839543PubMed
28028358Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.World J Gastroenterol2016https://conductscience.org/library/papers/28028358PubMed
27082580Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.Medicine (Baltimore)2016https://conductscience.org/library/papers/27082580PubMed
26360046A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).PLoS One2015https://conductscience.org/library/papers/26360046PubMed
26255287Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Clin Pharmacokinet2016https://conductscience.org/library/papers/26255287PubMed

See all 37 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TPMT7172PubTator's text mininghttps://conductscience.org/library/genes/7172

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16633046

GET https://conductscience.org/api/papers/v1/16633046/cited_by?page=2